480 related articles for article (PubMed ID: 20937457)
1. Epidemiology and management of hepatocellular carcinoma.
Yang JD; Roberts LR
Infect Dis Clin North Am; 2010 Dec; 24(4):899-919, viii. PubMed ID: 20937457
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.
Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ
Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609
[TBL] [Abstract][Full Text] [Related]
3. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand.
Somboon K; Siramolpiwat S; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(8):3567-70. PubMed ID: 24870758
[TBL] [Abstract][Full Text] [Related]
5. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
[TBL] [Abstract][Full Text] [Related]
6. Review article: the management of hepatocellular carcinoma.
Cabrera R; Nelson DR
Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
[TBL] [Abstract][Full Text] [Related]
7. Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil.
Kikuchi L; Chagas AL; Alencar RS; Paranaguá-Vezozzo DC; Carrilho FJ
Antivir Ther; 2013; 18(3 Pt B):445-9. PubMed ID: 23793796
[TBL] [Abstract][Full Text] [Related]
8. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
9. Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia.
Jazag A; Puntsagdulam N; Chinburen J
Korean J Intern Med; 2012 Jun; 27(2):121-7. PubMed ID: 22707881
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: global epidemiology.
Tabor E
Dig Liver Dis; 2001 Mar; 33(2):115-7. PubMed ID: 11346135
[No Abstract] [Full Text] [Related]
11. Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
Demirtas CO; Brunetto MR
World J Gastroenterol; 2021 Sep; 27(33):5536-5554. PubMed ID: 34588750
[TBL] [Abstract][Full Text] [Related]
12. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
[TBL] [Abstract][Full Text] [Related]
13. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
Sherman M
Semin Liver Dis; 2010 Feb; 30(1):3-16. PubMed ID: 20175029
[TBL] [Abstract][Full Text] [Related]
15. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
Amarapurkar D; Han KH; Chan HL; Ueno Y;
J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
Hallager S; Ladelund S; Kjaer M; Madsen LG; Belard E; Laursen AL; Gerstoft J; Røge BT; Grønbaek KE; Krarup HB; Christensen PB; Weis N
J Viral Hepat; 2018 Jan; 25(1):47-55. PubMed ID: 28750141
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: an emerging problem with hepatitis C.
Jeffers L
J Natl Med Assoc; 2000 Aug; 92(8):369-71. PubMed ID: 10992680
[TBL] [Abstract][Full Text] [Related]
18. The Changing Global Epidemiology of Hepatocellular Carcinoma.
Caines A; Selim R; Salgia R
Clin Liver Dis; 2020 Nov; 24(4):535-547. PubMed ID: 33012444
[TBL] [Abstract][Full Text] [Related]
19. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations.
Raptis I; Koskinas J; Emmanouil T; Hadziyannis S
J Viral Hepat; 2003 Nov; 10(6):450-4. PubMed ID: 14633179
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
